Last Updated: March 29, 2026

90+ Contract Manufacturing Statistics for 2025-2026

Contract manufacturing is a $724 billion global industry growing at roughly 6% per year. It spans electronics, pharmaceuticals, food and beverage, medical devices, automotive, and aerospace. Companies outsource production to reduce capital expenditure, access specialized capabilities, and scale faster than in-house factories allow. Understanding how big each sector is, where growth is concentrated, and what is driving outsourcing decisions can help original equipment manufacturers, procurement teams, and manufacturing service providers make better decisions.

We compiled over 90 data points from Mordor Intelligence, Grand View Research, Fortune Business Insights, Precedence Research, the Reshoring Initiative, Deloitte, and other authoritative market research and industry sources. Every statistic links to its original source so you can verify, cite, or use the data in your own reports and presentations.

$724B

Global contract manufacturing market size in 2025

84%

Organizations that outsource at least some manufacturing

5.98%

Projected CAGR through 2030 for the global CM market

What's in This Report

Global Contract Manufacturing Market Overview
North America and US Contract Manufacturing
Electronics Manufacturing Services (EMS)
Pharmaceutical CDMO Market
Medical Device Contract Manufacturing
Food and Beverage Contract Manufacturing
Automotive Contract Manufacturing
Aerospace and Defense
Why Companies Use Contract Manufacturers
Regional Breakdown: Asia, North America, Europe
Top Contract Manufacturing Companies
Key Trends Reshaping the Industry
Risks and Challenges
Cite This Report
Sources

Global Contract Manufacturing Market Overview

The global contract manufacturing market encompasses any arrangement where a company hires a third-party manufacturer to produce goods on its behalf under a contract. This includes contract electronics manufacturing (EMS), pharmaceutical contract development and manufacturing services (CDMO), food co-manufacturers, automotive tier-1 and tier-2 suppliers, and industrial component manufacturers. Contract type varies by relationship: fixed-price contracts (where the CM bears cost risk), cost-plus contracts (where the OEM pays actual costs plus a fee), and capacity-reservation contracts (where the OEM reserves production slots and pays regardless of volume).

This market analysis of the global contract manufacturing market in 2024 draws on data from over 20 market research reports covering manufacturing market size and share across sectors. The manufacturing technologies used by leading CMs have expanded significantly, from traditional CNC machining and injection molding to additive manufacturing, bioprocessing, and automated PCB assembly, creating new contract type options for OEMs seeking specialized capabilities. Key market players are detailed in the sector sections below, with a summary table in the Top Companies section.

Global Market Headlines

The global contract manufacturing market was valued at $724.35 billion in 2025 and is projected to reach $966.84 billion by 2030 at a CAGR of 5.98%. (Mordor Intelligence, 2025)
A separate forecast projects the contract manufacturing market will surpass $1 trillion by 2030 with a CAGR of 8.70%. (Mordor Intelligence Trends, 2025)
The overall global outsourcing market, including manufacturing, is projected to grow by $1.09 trillion at a CAGR of 6.82% by 2030. (360iResearch, 2025)
Asia-Pacific dominated the global contract manufacturing landscape, holding 45.67% of total 2024 revenue, driven by cost advantages, ecosystem density, and engineering talent concentration. (Mordor Intelligence, 2025)
The average manufacturer outsources 70% to 80% of its finished product value to third-party suppliers and contract manufacturers. (Find My Manufacturer, 2024)

Contract manufacturing has grown from a cost-reduction tactic into a core strategic capability. In earlier decades, companies outsourced primarily to take advantage of lower labor costs offshore. Today the calculus is more complex. Accessing specialized equipment, shortening time to market, managing variable demand, and tapping regulatory expertise in markets like pharmaceuticals have all become primary drivers. The sector spans everything from a small plastic injection molder running a few hundred thousand parts per month to a global electronics manufacturing services giant processing billions of components per day.

Market Dynamics, Segmentation, and Global Market Trends

Market dynamics in contract manufacturing are shaped by four structural forces: the cost of capital (which pushes companies toward asset-light outsourcing models during tight credit periods), technology complexity (which drives outsourcing when specialized capabilities cannot be built in-house cost-effectively), supply chain risk tolerance (which shifted sharply after COVID-19 disruptions toward dual-sourcing and nearshoring), and regulatory requirements (which create strong demand for CDMO and manufacturing of medical devices partners with pre-existing compliance infrastructure).

Contract manufacturing market segmentation runs along two primary dimensions: end-use industry (electronics, pharmaceuticals, food and beverage, automotive, aerospace, industrial, and consumer goods) and service type (design and engineering services, component manufacturing, sub-assembly, full product assembly, packaging, and distribution). A segmental analysis by contract type reveals further sub-divisions: full turnkey manufacturing (CM owns tooling and sourcing), consignment manufacturing (OEM supplies materials), and value-add assembly (CM adds process steps to OEM-supplied components). Companies selecting contract manufacturing partners must decide which market segmentation dimensions fit their product type, volume, and regulatory context before evaluating individual candidates.

Analysis of the global market shows that current market trends in contract manufacturing are converging around three themes: geographic diversification of supply chains away from single-country concentration, technology-enabled quality management through AI and automation, and evolution from transactional to outcome-based CM relationships. The market over the forecast period is expected to see consolidation, with market shares and rankings shifting as larger CMs acquire niche specialists and as OEMs consolidate their supplier bases to fewer, deeper CM partnerships. The global market for contract manufacturing is tracked across multiple market research reports with varying methodologies and scope definitions. The consensus market forecast puts compound annual growth rate between 5.98% and 8.70% for the 2025-2030 forecast period, with contract manufacturing market size and growth reaching roughly $966 billion to $1.12 trillion by 2030.

Demand for contract manufacturing services is expanding across all sectors, but the market is expanding fastest in life sciences (pharma and medical devices) and food and beverage, where OEM brands prefer to focus investment on brand building and distribution rather than production assets. Advanced contract manufacturing capabilities including cleanroom assembly, sterile fill-finish, biologics processing, and automated precision machining command significant price premiums and are concentrated among a small number of specialized providers in each sector.

Sector	2025 Market Size	CAGR	2030-2034 Projection
Electronics (EMS)	$648B	6.8%	$1.17T (2034)
Pharmaceutical (CDMO)	$197B	7.15%	$369B (2034)
Food and Beverage	$173B	9.6%	$395B (2034)
Medical Devices	$96B	10.33%	$157B (2030)
Automotive	$75B	5.80%	$112B (2032)

Sources: Mordor Intelligence, Fortune Business Insights, Precedence Research, Research and Markets (2025). Market size estimates vary across research firms; ranges are noted in sector sections below.

North America and US Contract Manufacturing

The United States is the largest single-country contract manufacturing market in North America and one of the most important globally. High labor costs relative to Asia make the US less competitive for pure assembly work, but advantages in regulatory infrastructure, proximity to end markets, intellectual property protection, and specialized technical capabilities sustain a large domestic CM industry.

US and North America Key Figures

The US contract manufacturing services market was valued at $265.78 billion in 2026 and is projected to reach $374.82 billion by 2031 at a CAGR of 7.12%. (Mordor Intelligence US Market Report, 2026)
The North America contract manufacturing services market was $64.5 billion in 2024 and is expected to grow at a CAGR of 6.8% through 2030. (Grand View Research, 2025)
The United States held 69.2% of North American contract manufacturing revenue in 2024, supported by advanced manufacturing infrastructure and strong life sciences and medical technology outsourcing. (Data Bridge Market Research, 2024)
North America's CDMO sector holds a 38.5% share of the global pharmaceutical CDMO market in 2025, driven by a dense network of contract manufacturers, high clinical trial volume, and strong pharma-biotech partnerships. (Fortune Business Insights, 2025)
Reshoring and nearshoring trends are shifting more contract production back to the US and Mexico. The Reshoring Initiative reported cumulative announcements of over 1.8 million jobs reshored or kept in the US since 2010. (Reshoring Initiative 2024 Annual Report)
The US Aerospace and Defense Electronic Manufacturing Services market was valued at $7.08 billion in 2025, growing at a CAGR of 3.15% to reach $9.65 billion by 2035. (SNS Insider, 2025)

The US contract manufacturing industry is particularly concentrated in pharmaceuticals, medical devices, and advanced electronics. These sectors value regulatory competence, quality management systems (ISO, FDA GMP, AS9100), and proximity to R&D centers over pure production cost. The CHIPS and Science Act of 2022 is also catalyzing investment in domestic semiconductor contract manufacturing, with companies like TSMC, Samsung, and Intel expanding or establishing US foundry operations.

Electronics Manufacturing Services (EMS)

Electronics manufacturing services represent the largest segment of the global contract manufacturing market by revenue. EMS companies handle printed circuit board assembly (PCBA), system integration, design for manufacture (DFM), supply chain management, and product lifecycle services for consumer electronics, industrial equipment, telecommunications, and medical electronics customers.

EMS Market Statistics

The global EMS market was valued at $648.11 billion in 2025 and is projected to grow to $1.167 trillion by 2034 at a CAGR of 6.8%. (Fortune Business Insights, 2025)
A separate estimate puts EMS at $627.7 billion in 2024, reaching $1.09 trillion by 2033 at a CAGR of 6.3%. (SkyQuest Technology, 2025)
Electronic contract manufacturing and design services combined are estimated at $790 billion in 2025, reaching $1.64 trillion by 2032 at a CAGR of 11.0%. (Coherent Market Insights, 2025)
Asia-Pacific accounts for the largest share of EMS revenue. China's orchestration of wafer fabs, substrate suppliers, and final assembly under concentrated clusters sustains scale advantages that Western manufacturers have struggled to replicate. (Mordor Intelligence, 2025)
Foxconn (Hon Hai Precision Industry), Jabil, Flex Ltd., Celestica, and Wistron are the five largest global EMS companies by revenue. (Mordor Intelligence, 2025)
EMS companies are investing heavily in fully automated SMT lines, digital-twin production systems, AI-driven quality inspection, and robotics to boost yield and reduce defect rates. (Precedence Research, 2026)
The US EMS sector is growing, with companies like Jabil and Flex expanding US facilities partly in response to CHIPS Act incentives and customer preferences for domestic supply. (Logistics Viewpoints, 2025)

Pharmaceutical Contract Development and Manufacturing (CDMO)

Pharmaceutical CDMOs provide drug development, formulation, and commercial-scale manufacturing services to biotech and pharmaceutical companies. They handle API manufacturing (active pharmaceutical ingredient synthesis), drug product formulation, fill-and-finish operations, and regulatory support. The sector surged after COVID-19 demonstrated the value of flexible, scalable manufacturing capacity. The forecast period of 2025 to 2030 is expected to bring sustained double-digit growth for biologic and cell therapy CDMO capacity.

Pharmaceutical CDMO Statistics

The global pharmaceutical CDMO market was valued at $155.5 billion in 2024 and is projected to reach $293.6 billion by 2033 at a CAGR of 7.38%. (Grand View Research, 2025)
A separate estimate puts the pharma CDMO market at $197.40 billion in 2025, reaching $368.70 billion by 2034 at a CAGR of 7.15%. (Precedence Research, 2025)
Another forecast from Straits Research values the pharmaceutical CDMO market at $200.9 billion in 2024 and projects $378.94 billion by 2033. (Straits Research, 2025)
North America holds a 38.5% share of the global CDMO market in 2025, the largest regional share, driven by a high density of clinical-stage companies and strong regulatory expertise. (Fortune Business Insights, 2025)
Pharmaceutical manufacturing services account for the largest share of the CDMO market and are expected to maintain that lead through at least 2025, driven by rising demand for large-scale GMP production. (MarketsandMarkets, 2025)
Biologics manufacturing is the fastest-growing CDMO subsegment, fueled by expansion of biosimilars, cell and gene therapies, and mRNA-based drug platforms. (Grand View Research, 2025)

The pharmaceutical CDMO sector, where CDMO stands for contract development and manufacturing organization, is highly fragmented globally but more concentrated in North America and Europe, where regulatory standards are strictest. Small and mid-size biotech companies without their own manufacturing facilities rely almost entirely on CDMOs to take candidates from clinical trials through commercial launch. That dependency has made CDMO selection and relationship management a critical strategic capability for biopharma. Market trends in drug manufacturing show continued consolidation, with larger CDMOs acquiring smaller specialists to offer broader service portfolios.

Major pharmaceutical contract manufacturing organizations include Lonza Group, Catalent (acquired by Novo Holdings in 2024), Thermo Fisher Scientific (which operates a large CDMO business through its Pharma Services division), Samsung Biologics, WuXi AppTec, and Patheon. Thermo Fisher Scientific holds a significant share of North American CDMO capacity across small-molecule, biologics, and drug manufacturing services. CDMOs with biologics manufacturing capabilities including mRNA, cell therapy, and gene therapy platform capacity are the most sought-after market players during the current market trends cycle. The pharmaceutical CDMO market is expected to grow at 7.15-7.38% CAGR over the forecast period, with market estimates ranging from $293 billion to $379 billion by 2033-2034 depending on research firm methodology. Good manufacturing practices (GMP) compliance, continuous manufacturing capability, and multi-modal manufacturing site networks are now standard differentiators for top-tier CDMOs. The market size was valued at $155-200 billion in 2024 depending on the research scope.

Medical Device Contract Manufacturing

Medical device contract manufacturers produce implantable devices, diagnostic equipment components, surgical instruments, patient monitoring hardware, and wearable health technology. The sector demands ISO 13485 certification, FDA design controls, and strict traceability, which creates high barriers to entry and supports premium pricing compared to other contract manufacturing segments.

Medical Device CM Statistics

The global medical device contract manufacturing market was valued at $92.6 billion in 2025 and is projected to reach $181.4 billion by 2035 at a CAGR of 6.9%. (Roots Analysis, 2025)
A second estimate puts the market at $95.81 billion in 2025, reaching $156.63 billion by 2030 at a CAGR of 10.33%. (Mordor Intelligence, 2025)
Precedence Research projects the market could reach $253.86 billion by 2034, representing a CAGR of approximately 10.89% from 2025 levels of $100.5 billion. (Precedence Research, 2025)
Fortune Business Insights values the market at $87.43 billion in 2025 and projects $252.95 billion by 2034, a CAGR of 12.53%. (Fortune Business Insights, 2025)
The market is highly fragmented. The top five companies, including Jabil, Flex, Integer Holdings, Plexus, and Sanmina, collectively hold only 15% to 20% of global market share. (MarketsandMarkets, 2025)
Growth drivers include an aging global population, increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, and outsourcing by OEMs seeking to reduce capital expenditure in a high-regulatory-cost environment. (Mordor Intelligence, 2025)

Food and Beverage Contract Manufacturing

Food co-manufacturing (also called contract food manufacturing) occurs when a brand owner contracts a licensed food facility to produce packaged goods. It is used extensively by consumer packaged goods (CPG) companies, private label retailers, meal kit providers, and emerging food and beverage brands that lack their own production capacity. The sector is governed by FDA food safety rules, FSMA compliance requirements, and often by retail buyer codes of practice.

Food and Beverage Contract Manufacturing Statistics

The global food contract manufacturing market was valued at $173.30 billion in 2025 and is projected to reach $395.45 billion by 2034, a CAGR of 9.6%. (Towards FnB, 2025)
A second estimate places the market at $170.90 billion in 2024, reaching $186.62 billion in 2025 and $283.09 billion by 2030 at a CAGR of 8.77%. (360iResearch, 2025)
Grand View Research pegged the market at $131.2 billion in 2022, projecting $274.7 billion by 2030 at a CAGR of 9.7%. (Grand View Research, 2023)
The Research and Markets report values the food contract manufacturing market at $185.03 billion in 2025, growing from $168.54 billion in 2024 at a CAGR of 9.8%. (Research and Markets, 2025)
Market.us projects food contract manufacturing will reach $388.7 billion by 2035 from $176.7 billion in 2025, a CAGR of 8.2%. (Market.us, 2025)
Key growth drivers include demand for cost efficiency among CPG brands, focus on core competencies in marketing and distribution, and market expansion into new geographies by brands that cannot build local production. (Research and Markets, 2025)

The food co-manufacturing market in North America benefits from a well-developed cold chain, dense food processing hub locations (Midwest, Central Valley California, and Southeast), and strong retail infrastructure. The rise of e-commerce grocery, meal kits, and direct-to-consumer food brands has created demand for smaller batch co-manufacturers alongside the traditional large-scale CPG contract facilities.

Automotive Contract Manufacturing

Automotive contract manufacturing encompasses entire vehicle assembly by contract assemblers, as well as component and sub-assembly outsourcing to tier-1 and tier-2 suppliers. The electric vehicle transition has reshaped the sector. EV platforms use fewer unique mechanical parts than internal combustion engines, making component outsourcing more tractable, while battery pack and power electronics manufacturing has created new specialized contract manufacturing demand.

Automotive Contract Manufacturing Statistics

The global automotive contract manufacturing market was valued at $176.8 billion in 2025 and is projected to reach $296.7 billion by 2035 at a CAGR of 5.4%. (OMR Global, 2025)
Research and Markets estimates the automotive CM market at $71.28 billion in 2024, reaching $75.17 billion in 2025 and $111.99 billion by 2032 at a CAGR of 5.80%. (Research and Markets, 2025)
Cognitive Market Research estimates the automotive CM market at $66.6 billion in 2024, projecting a CAGR of 9.70% through 2031. (Cognitive Market Research, 2024)
Market growth is being driven by increased OEM outsourcing for cost savings, the rise of EV platforms with new component requirements, and demand for flexible manufacturing partnerships to handle model year transitions. (OMR Global, 2025)
Large contract vehicle assemblers such as Magna International and Valmet Automotive have expanded capacity in North America and Europe to serve EV startup brands that lack proprietary factories. (Logistics Viewpoints, 2025)

Aerospace and Defense Contract Manufacturing

Aerospace and defense contract manufacturing is one of the most technically demanding segments, requiring AS9100 quality management certification, ITAR compliance, and strict traceability for every component. Defense budget expansion, commercial aviation demand recovery, and the growth of the space economy have all driven increased outsourcing demand in this segment.

Aerospace Contract Manufacturing Statistics

The US Aerospace and Defense Electronic Manufacturing Services market was valued at $7.08 billion in 2025, projected to reach $9.65 billion by 2035 at a CAGR of 3.15%. (SNS Insider, 2025)
By service type, manufacturing services led the US Aerospace and Defense market with a 62.76% revenue share in 2025. (Mordor Intelligence, 2026)
The US aerospace and defense industry boasted a $73.86 billion trade surplus in 2025, exporting nearly $139 billion in A&D technology, making it one of the few US manufacturing sectors with a sustained trade surplus. (Aerospace Industries Association, 2025)
Space platforms posted the fastest growth at a 7.12% CAGR, while aerial platforms commanded 31.25% revenue share of the US A&D market in 2025. (Mordor Intelligence, 2026)
Deloitte's 2026 aerospace and defense outlook identifies AI, digital skills, and software-defined systems as the dominant investment and hiring themes, with AI-related job postings in aerospace manufacturing growing significantly from 2019 through 2025. (Deloitte 2026 A&D Industry Outlook)

Why Companies Use Contract Manufacturers

The motivations behind contract manufacturing decisions have shifted significantly over the past decade. Cost reduction dominated for most of the 2000s and 2010s. Today, talent access, speed, specialization, and supply chain resilience are increasingly cited as primary drivers alongside cost.

Outsourcing Decision Statistics

Approximately 84% of organizations surveyed outsource at least some aspects of their manufacturing rather than producing entirely in-house. (Schott Magnetics, citing industry survey)
Cost reduction as the top outsourcing driver dropped from 70% in 2020 to 34% in 2024, a decline of 51% in four years. (Drew EB Design, citing Deloitte 2024 survey data)
42% of executives in 2024 identified access to specialized talent as the top reason to use contract manufacturers, surpassing cost reduction for the first time. (Drew EB Design, citing Deloitte 2024 survey data)
Deloitte's Global Outsourcing Survey 2024 found that skilled talent and agility have joined cost reduction as key drivers, with outcome-based delivery models growing in adoption. (Deloitte Global Outsourcing Survey, 2024)
83% of executives surveyed by Deloitte in 2024 are leveraging AI as part of their outsourced services, with 20% already developing strategies to manage AI-driven digital workers alongside human contractors. (Deloitte Canada, Global Outsourcing Survey 2024)
Despite the prevalence of outsourcing, 70% of organizations have also brought some previously outsourced work back in-house, even among those highly satisfied with their CM relationships, reflecting a push for supply chain resilience. (NetSuite, citing Deloitte 2024)
Companies are most likely to use contract manufacturing for newly developed products or those with long production cycles. Products with shorter cycles or high customization tend to be handled in-house. (Supply Chain Management Review / e2open Survey)

Reason for Outsourcing	% Citing as Driver (2024)	Change vs. 2020
Access to specialized talent	42%	+Rising
Cost reduction	34%	Down from 70%
Agility and speed to market	Rising	+Growing
Access to AI/digital capabilities	83%	New driver

Source: Deloitte Global Outsourcing Survey, 2024

Regional Breakdown: Asia, North America, and Europe

Contract manufacturing is geographically concentrated. Asia-Pacific dominates by volume, particularly in electronics and apparel. North America leads in pharmaceutical CDMOs, medical devices, and aerospace. Europe holds a significant share in automotive and precision engineering contract manufacturing.

Regional Market Data

Asia-Pacific held 45.67% of global contract manufacturing revenue in 2024, driven by China's integrated supply chain clusters, lower labor costs, and scale in electronics. (Mordor Intelligence, 2025)
The US held 69.2% of North American CM revenue in 2024, with Canada and Mexico accounting for the remaining 30.8%. (Data Bridge Market Research, 2024)
Mexico is emerging as one of the fastest-growing nearshore contract manufacturing destinations for US companies. Nearshoring to Mexico reduces lead times by 4-6 weeks compared to Asian suppliers for North American markets. (Procurement Tactics, 2025)
North America's CDMO sector holds a 38.5% share of the global pharmaceutical CDMO market in 2025. (Fortune Business Insights, 2025)
The Reshoring Initiative reports that cumulative reshoring and FDI job announcements have exceeded 1.8 million since 2010, with 2024 showing continued momentum driven by CHIPS Act investments, IRA incentives, and tariff policy changes. (Reshoring Initiative 2024 Annual Report)
China's orchestration of wafer fabs, substrate suppliers, and final assembly under concentrated clusters sustains scale advantages that Western manufacturers have struggled to replicate, keeping Asia-Pacific dominant in electronics CM despite geopolitical pressures. (Mordor Intelligence, 2025)

Top Contract Manufacturing Companies

The contract manufacturing industry is dominated by a handful of global giants in electronics, while pharmaceutical CDMOs and medical device manufacturers are more fragmented. Here is an overview of major players across key segments.

Sector	Major Players	Market Concentration
Electronics (EMS)	Foxconn, Jabil, Flex Ltd., Celestica, Wistron	Concentrated; top 5 hold majority share
Pharmaceutical CDMO	Lonza, Catalent, Patheon (Thermo Fisher), Samsung Biologics, WuXi AppTec	Moderately fragmented
Medical Devices	Jabil, Flex, Integer Holdings, Plexus, Sanmina	Highly fragmented; top 5 hold 15-20%
Automotive	Magna International, Valmet Automotive, Karmann, Pininfarina	Fragmented by region and process

Sources: Mordor Intelligence; MarketsandMarkets, 2025

Jabil and Flex Ltd. are the only companies with significant market presence across multiple sectors, including electronics, medical devices, and industrial manufacturing. Foxconn dominates consumer electronics assembly but has been diversifying into EV manufacturing and semiconductor packaging. These large EMS firms are also evolving from pure contract assemblers into full supply chain orchestrators, managing tier-2 and tier-3 supplier networks, logistics, and analytics platforms for their OEM customers. (Logistics Viewpoints, 2025)

Key Trends Reshaping Contract Manufacturing

The contract manufacturing industry is undergoing significant structural change. Several concurrent forces are reshaping where production happens, who does it, and how it is managed. Understanding market trends across the forecast period is essential for OEMs deciding where to locate production and for CM providers deciding where to invest.

Market Outlook and Forecast Summary

The market outlook for contract manufacturing services remains strongly positive across all major segments. Electronics held the largest market share in 2024 by absolute revenue, while medical devices and food contract manufacturing are posting the fastest growth rates during the forecast period. The contract manufacturing services market size in the US is growing faster than the global average, driven by reshoring incentives, supply chain diversification strategies, and a growing biotech industry.

Segment	Market Share in 2024	Growth Outlook
Electronics (EMS)	Largest (45%+ via Asia)	6.3-6.8% CAGR to 2034
Pharmaceutical CDMO	2nd largest by value	7.15-7.38% CAGR to 2033
Food and Beverage	$170-173B in 2024	8.77-9.8% CAGR, fastest growing
Medical Devices	$88-96B in 2024/2025	10.33-12.53% CAGR
Automotive	$66-71B in 2024	5.4-9.7% CAGR

Sources: Multiple market research reports. See Sources section for full citations. Market in 2024 figures vary by research firm scope and methodology.

Reshoring and Nearshoring

Cumulative reshoring and FDI job announcements have exceeded 1.8 million since 2010, with 2024 activity boosted by CHIPS Act investments, Inflation Reduction Act manufacturing incentives, and tariff policy changes. (Reshoring Initiative 2024 Annual Report)
The typical CM reshoring scenario involves an OEM customer with US sales volume shifting production from Asian contract manufacturers back to domestic or nearshore partners to reduce lead times and supply chain risk. (Reshoring Initiative 2025 Survey Report)
Despite reshoring trends, Asia-Pacific maintained 45.67% of global CM revenue in 2024, indicating that cost and ecosystem advantages continue to sustain offshore contract manufacturing in volume-sensitive categories. (Mordor Intelligence, 2025)
Mexico and Vietnam have emerged as major nearshoring destinations. Vietnam specializes in apparel, footwear, and electronics assembly; Mexico in automotive, medical devices, and electronics serving North American markets. (Procurement Tactics, 2025)

Automation and AI in Contract Manufacturing

83% of surveyed executives in 2024 are leveraging AI as part of their outsourced services, and 20% are already developing strategies to manage AI-driven digital workers alongside contract staff. (Deloitte Canada, 2024)
Leading EMS companies including Foxconn, Jabil, and Flex are investing in fully automated SMT assembly lines, digital twin production systems, and AI-driven quality inspection to boost yield and reduce defects across their global factory networks. (Precedence Research, 2026)
AI adoption in outsourcing is evolving from back-office automation toward front-office and core production capabilities. Outcome-based delivery models, where the CM is paid for results rather than time, are growing in adoption alongside AI. (Deloitte Global Outsourcing Survey, 2024)

Outcome-Based and Strategic Partnerships

The relationship between OEMs and contract manufacturers is evolving from transactional to strategic. Rather than simply buying production capacity, leading companies now form multi-year partnerships where the CM co-designs manufacturing processes, manages supply chain sub-tiers, and contributes to product development. Deloitte's 2024 Global Outsourcing Survey identified this shift toward outcome-based models, where CMs are compensated for performance metrics like yield, quality, and on-time delivery rather than just labor hours. (Deloitte, 2024)

Risks and Challenges in Contract Manufacturing

Despite its growth, contract manufacturing carries significant operational and strategic risks. Understanding these risks is essential for companies evaluating whether to outsource production and how to structure CM relationships.

Risk Category	Key Issues	Most Affected Sectors
Quality and compliance	Defects, regulatory failures, GMP violations	Pharma, Medical Devices, Food
Supply chain concentration	Single-source suppliers, geographic concentration	Electronics, Automotive
Intellectual property	Design theft, trade secret leakage offshore	All sectors
Lead time and flexibility	Inability to respond quickly to demand changes	Consumer electronics, CPG
Geopolitical risk	Tariffs, export controls, trade sanctions	Electronics, Semiconductors

Risk Statistics

Despite high outsourcing rates, 70% of organizations have brought previously outsourced work back in-house at some point, often citing quality control concerns and loss of institutional knowledge as primary drivers. (NetSuite, citing Deloitte 2024)
Quality issues in contract manufacturing most commonly stem from improper equipment management, inadequate supplier auditing, insufficient process documentation, and communication gaps between the OEM's design intent and the CM's production interpretation. (ComplianceQuest, 2025)
The most damaging consequence of poor CM quality is loss of customer trust, which affects not just current contracts but future bids and brand perception in markets where quality incidents become public. (POWERS Management Consulting, 2025)
Companies that use contract manufacturing for newly developed products face higher quality risk during ramp-up than those using established product lines, because process validation with an external manufacturer takes longer than with an in-house team. (Supply Chain Management Review / e2open Survey)

Turn Your Manufacturing Website Into a Lead Engine

Get the free 5-day email course: the 5 fixes that turn your site from a brochure into an RFQ machine.

Get the Free 5-Day Course →

Cite This Report

If you reference these statistics in your content, research, or presentations, please use the following citation format:

Manufacturing Lead Generation. "90+ Contract Manufacturing Statistics (2025-2026)." ManufacturingLeadGeneration.com. March 29, 2026. https://manufacturingleadgeneration.com/contract-manufacturing-statistics/

Individual statistics must be attributed to their original sources as listed in the Sources section below. Each data point in this report links directly to its primary source.

Sources

Every statistic in this report links to its original source. Below is a complete list of the primary sources referenced.